Joint Clinical Trials Office
A Randomized Phase 2 Trial of ASTX727 +/- Iadademstat in Accelerated/Blast-Phase Philadelphia Chromosome-Negative Myeloproliferative Neoplasms (MPNs)
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 14, 2026
A Phase II Trial of Durvalumab with Gemcitabine and Cisplatin as Neoadjuvant Therapy for High-Risk Resectable Intrahepatic Cholangiocarcinoma
Study Status:
Open to Enrollment
Primary Investigator:
Date: January 30, 2026
A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of ITK Inhibitor Soquelitinib Versus Physician’s Choice Standard of Care Treatment (Selected Single Agent) in Participants with Relapsed/Refractory Peripheral T-cell Lymphoma
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 6, 2026
A Phase 1 study of BAL0891 as monotherapy and in combination with chemotherapy in patients with advanced solid tumors or relapsed or refractory acute myeloid leukemia
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 6, 2026
A Phase 1b/2, Multicenter, Randomized, Open-Label Study to Evaluate The Efficacy And Safety Of GSK5764227 Alone And In Combination In Participants With Previously Treated Advanced Unresectable Or Metastatic Gastrointestinal Solid Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 6, 2026
A Randomized Study Evaluating 2 Dose Regimens of Dupilumab in Children ≥6 Months of Age Weighing ≥5 to <15 kg With Active Eosinophilic Esophagitis
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 9, 2026
Repository of Novel Analytes Leading to Autoimmune, Inflammatory, and Diabetic Nephropathies (RENAL AID)
Study Status:
Open to Enrollment
Primary Investigator:
Alan Perlman, M.D.
Date: March 15, 2016
(CLONEVO): Cell cycLe inhbitiON to target the EVolution of urOthelial cancer
Study Status:
Open to Enrollment
Primary Investigator:
Bishoy Faltas, M.D.
Date: June 8, 2018
Autosomal Dominant Polycystic Kidney Disease Data Repository
Study Status:
Open to Enrollment
Primary Investigator:
Blumenfeld, Jon M.D.
Date: April 28, 2016
Fecal Microbiota Transplantation National Registry
Study Status:
Open to Enrollment
Primary Investigator:
Carl V. Crawford, Jr., MD
Date: August 24, 2018